Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta

Go back to Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
Abbott Laboratories (NYSE: ABT) Delayed: 106.20 +1.63 (1.56%)
Previous Close $104.57    52 Week High $46.38 
Open $106.15    52 Week Low $36.00 
Day High $106.85    P/E 70.80 
Day Low $104.60    EPS $1.50 
Volume 8,440,807       

Amgen Inc (NASDAQ: AMGN) Delayed: 466.01 +5.28 (1.15%)
Previous Close $460.73    52 Week High $176.85 
Open $470.15    52 Week Low $133.64 
Day High $475.65    P/E 70.18 
Day Low $465.33    EPS $6.64 
Volume 3,290,610       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 49.51 +0.83 (1.71%)
Previous Close $48.68    52 Week High $45.58 
Open $49.84    52 Week Low $37.82 
Day High $50.28    P/E N/A 
Day Low $49.25    EPS $0.00 
Volume 4,767,295       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147       

Johnson & Johnson (NYSE: JNJ) Delayed: 273.20 -2 (0.73%)
Previous Close $275.20    52 Week High $126.07 
Open $280.00    52 Week Low $94.28 
Day High $282.02    P/E 56.80 
Day Low $273.13    EPS $4.81 
Volume 8,969,378       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 61.27 +0.50 (0.82%)
Previous Close $60.77    52 Week High $35.13 
Open $61.09    52 Week Low $28.10 
Day High $61.44    P/E N/A 
Day Low $60.75    EPS $0.00 
Volume 1,468,062